95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists
#1502Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
#1503Anthelmintic quinoline-3-carboxamide derivatives
#1504Heterocyclic compounds as immunomodulators
#1505Small molecule inducers of autophagy
#1506Amido compounds as AhR modulators
#1507Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#1508INHIBITION OF OLIG2 ACTIVITY
#1509Indole derivatives and their use as protein kinase inhibitors
#1510Pyrimidine derivatives as PGE2 receptor modulators
#1511Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders
#1512OX2R compounds
#1513Compositions and Methods of Using the Same for Treatment of Neurodegenerative and Mitochondrial Disease
#1514Histone methyltransferase inhibitors
#1515Urea derivative or pharmacologically acceptable salt thereof
#1516Compound and organic light-emitting device including the same
#1517Splicing modulator antibody-drug conjugates and methods of use
#1518Cannabinergic compounds and uses thereof
#1519Anti-infective agents
#1520COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1521Pyrimidine compounds useful as tyrosine kinase inhibitors
#1522Carboxamides as modulators of sodium channels
#1523SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#1524Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof
#1525Neprilysin inhibitors
#1526MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
#1527Compound and pharmaceutical composition comprising same
#1528QUINAZOLINE DERIVATIVE AND USE THEREOF
#1529Human plasma kallikrein inhibitors
#1530Arginine methyltransferase inhibitors and uses thereof
#1531Apelin receptor (APJ) agonists and uses thereof
#1532Pesticidal compounds
#1533Pharmaceutically Active Compounds
#1534PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#1535DNA-PK inhibitors
#1536Methods and compositions of inhibiting DCN1-UBC12 interaction
#1537Process and crystalline forms of Lumacaftor
#1538P300/CBP hat inhibitors
#1539AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF
#1540Substituted benzene compounds
#1541PLANT GROWTH REGULATOR COMPOUNDS
#1542ANTIVIRAL COMPOUNDS
#1543Inhibitors of protein arginine deiminases
#15441H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
#1545Process and crystalline forms of lumacaftor
#1546Combination therapy for treating cancer
#1547Heterocyclic compounds as pesticides
#1548Compounds and methods for treating oxalate-related diseases
#1549COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#1550Immunomodulator compounds
#1551Inhibitors of RAS-effector protein interactions
#1552Bromodomain Inhibitors
#15532-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same
#1554PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#1555Human plasma kallikrein inhibitors
#1556Human plasma kallikrein inhibitors
#1557Herbicidal compounds
#1558Pyridone amides as modulators of sodium channels
#1559Benzamide compound and preparation method, use, and pharmaceutical composition thereof
#1560TRIGONELLINE BASED COMPOUNDS
#1561Fluorogenic pH sensitive dyes and their method of use
#1562Photolabile barbiturate compounds
#1563Therapeutics for the treatment of glaucoma
#1564Inhibitors of RAD52 Recombination Protein and Methods Using Same
#1565Compounds for the treatment of kinase-dependent disorders
#1566Compounds for the treatment of kinase-dependent disorders
#1567NTCP inhibitors
#1568QUINOLINE DERIVATIVES AND PREPARATION METHODS AND USES THEREOF
#1569Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application
#1570PSMA Imaging Agents
#1571COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
#1572Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
#1573Inhibitors of Beta-Hydroxylase for Treatment of Cancer
#1574Compounds and their use as PDE4 activators
#1575Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone
#1576Insecticidal compositions and methods
#1577PSMA imaging agents
#1578Polymorphic forms of Afatinib free base and Afatinib dimaleate
#1579Modulators of ATP-binding cassette transporters
#1580Bicyclic carboxamides and methods of use thereof
#1581Cyclopropylamines as LSD1 inhibitors
#1582Compounds for treating mitochondrial disease
#1583BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
#1584Compounds
#1585Pyrimidine derivatives for the treatment of viral infections
#1586Apparatus for coupling to existing power lines
#1587Heterocyclic compounds as immunomodulators
#1588HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION
#1589N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
#1590AHR inhibitors and uses thereof
#1591Heterocyclic compounds as pesticides
#1592Nitrobenzyl derivatives of anti-cancer agents
#1593Theramutein modulators
#1594Compound for organic electric element, organic electric element comprising the same, and electronic device thereof
#1595Compounds
#1596Micronized 1,4-di(benzoxazol-2′-yl)benzene
#1597Methods for 1,4-diazo N-heterocycle synthesis
#1598DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#1599MCT4 inhibitors for treating disease
#1600Histone demethylase inhibitors
#1601Theramutein modulators
#1602Sulfonyl acetamides as NLRP3 inhibitors
#1603Pyrazole-containing macrophage migration inhibitory factor inhibitors
#1604Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#1605Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#1606Methods and compounds for restoring mutant p53 function
#1607Triazabutadienes as cleavable cross-linkers
#1608PKM2 MODULATORS AND METHODS FOR THEIR USE
#1609Oxoacridinyl acetic acid derivatives and methods of use
#1610Catalysts and methods for enantioselective conjugate addition of amines to unsaturated electrophiles
#1611Methods for treating depressive symptoms
#1612Compositions and methods for treating infections
#1613BRD4-kinase inhibitors as cancer therapeutics
#1614Tead inhibitors and uses thereof
#1615ALKYNYL PYRIDINE PROLYL HYDROXYLASE INHIBITOR, AND PREPARATION METHOD AND MEDICAL USE THEREOF
#16163-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#1617Triazine derivatives for treating diseases relating to neurotrophins
#16183-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#1619DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
#1620Unusually potent ABA receptor pan-antagonists
#1621Calpain modulators and therapeutic uses thereof
#1622Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
#1623Preparation containing benzimidazole derivative
#1624Processes for preparing antiviral compounds
#1625Process for producing a hydrate of a hydrochloride salt of 2,2′-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid
#1626NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#1627Isofuranone compounds useful as HPK1 inhibitors
#1628Modifiers of CFTR-directed therapy
#1629Acid addition salts of piperazine derivatives
#1630Calcium channel inhibitors
#1631Quinoline sulfonamide compounds and their use as antibacterial agents
#1632Substituted pyrrolidine compound and use thereof
#1633Cholecystokinin B receptor targeting for imaging and therapy
#1634Compounds
#1635Triaryl compounds for treatment of PD-L1 diseases
#1636PSMA imaging agents
#1637Bicyclic-fused heteroaryl or aryl compounds
#1638DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF
#1639SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#1640Quinoline derivatives for treating infections with helminths
#1641Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
#1642NEW ANTI-MALARIAL AGENT
#16432,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
#1644Substituted piperazines as selective HDAC1,2 inhibitors
#1645Anti-inflammatory compound, and preparation and use thereof
#1646Pegylated carfilzomib compounds
#1647Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6
#1648Compounds and compositions for the treatment of cystic fibrosis
#1649COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF
#1650Substituted imidazole carboxylate derivatives and the use thereof
#1651INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
#1652Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
#1653TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#1654Hydantoin derivatives useful as Kv3 inhibitors
#1655Compounds, compositions, and methods of increasing CFTR activity
#1656Redundant power line control systems
#1657Biocompatible modular tetrazine platform
#1658Compositions and methods for viral sensitization
#1659Benzofuran derivative, preparation method thereof and use thereof in medicine
#1660Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors
#1661MODULATORS OF THE INTEGRATED STRESS PATHWAY
#1662Chromene derivatives as inhibitors of TCR-Nck interaction
#1663QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE
#1664Compounds and compositions for inhibition of FASN
#1665HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#1666ORGANIC LIGHT-EMITTING DIODE
#1667COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA
#1668CXCR2 antagonist
#1669AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#1670Inhibitors of dihydroceramide desaturase for treating disease
#1671BENZAMIDE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE CONTAINING SAME AS ACTIVE INGREDIENT
#1672Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof
#1673Catecholamine prodrugs for use in the treatment of Parkinson's disease
#1674Compositions and methods for treating EZH2-mediated cancer
#1675Methionine metabolic pathway inhibitors
#1676Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#1677Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
#1678EZH2 inhibitors for treating lymphoma
#1679Pyrimidine derivative kinase inhibitors
#1680Pyrrole compounds
#1681Aromatic amine derivative, and organic electroluminescent element using same
#1682Cyclic peroxides as prodrugs for selective delivery of agents
#1683Modulators of methyl modifying enzymes, compositions and uses thereof
#1684Azole analogues and methods of use thereof
#16855-hydroxytryptamine receptor 7 activity modulators and their method of use
#1686Compounds and their use as selective inhibitors of caspase-2
#1687PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
#1688Sulfonamide carboxamide compounds
#1689Anticancer agent
#1690Benzo-fused heterocyclic derivatives useful as agonists of GPR120
#1691BICYCLIC QUINAZOLINONE DERIVATIVES
#1692Selective inhibition of gluconeogenic activity
#1693Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
#1694ErbB/BTK inhibitors
#1695Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents
#1696Aromatic amine derivative, and organic electroluminescent element using same
#1697Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#1698Substituted ureas and methods of making and using same
#1699Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
#1700Substituted quinazolines for inhibiting kinase activity
#1701Materials for electronic devices
#1702Androgen receptor modulating compounds
#1703Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors
#1704WNT signaling pathway inhibitors for treatments of disease
#1705Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
#1706COLORED PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT SHIELDING SPACER PREPARED THEREFROM
#1707Compositions for treating neurodegenerative diseases
#1708PYRIMIDINEDIONE COMPOUNDS
#1709Chemical compounds
#1710BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF
#1711CONTROLLING ZONES OF ELECTRONIC DEVICES ASSOCIATED WITH POWER LINES
#1712Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
#17132,3-dihydrobenzohurans as bromodomain inhibitors
#1714Benzofuran derivatives for the treatment of hepatitis C
#1715Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
#1716Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#1717Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
#1718Farnesoid X receptor agonists and uses thereof
#1719Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor
#1720PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#1721Benzofuran derivatives and their use as bromodomain inhibitors
#1722Compounds for improving mRNA splicing
#1723ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#1724HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#1725Neprilysin inhibitors
#17262-phenylpyrimidine-4-carboxamides as AHR inhibitors
#1727Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases
#1728Materials for electronic devices
#1729Salts and prodrugs of 1-methyl-d-tryptophan
#1730MEK inhibitors and methods of their use
#1731Small molecule regulators of mitochondrial fusion and methods of use thereof
#1732Radiolabeled Darapladib and analogs thereof and their use as imaging compounds
#1733Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor
#1734QUINOLINE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE
#1735Microbiocidal quinoline (thio)carboxamide derivatives
#1736Pyridinium salt and pest control agent
#1737Fused indazole pyridone compounds as antivirals
#1738Compounds, salts thereof and methods for treatment of diseases
#1739Pyrimidinyloxy benzene derivatives as herbicides
#1740INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
#1741Compounds, compositions and methods of use
#1742Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N, N-dialkylanilines
#1743Small molecules against cancer
#1744SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY
#1745Inhibitors of hepatitis C virus replication
#1746METHODS OF TREATING CANCER
#1747Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
#17486-membered heterocyclic derivatives and pharmaceutical composition comprising the same
#1749Compositions and methods for treating cancer
#1750Antibacterial compounds
#1751Imidazolecarboxamides and Their Use as FAAH Inhibitors
#1752Potassium channel inhibitors
#1753Quinazolines as potassium ion channel inhibitors
#1754Microbiocidal picolinamide derivatives
#1755Hydantoin containing deoxyuridine triphosphatase inhibitors
#1756Quinazoline compounds as modulators of Ras signaling
#1757Hetero-halo inhibitors of histone deacetylase
#1758Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
#1759ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#1760Quinazolinones as PARP14 inhibitors
#1761PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#1762K-Ras modulators
#1763Compounds, compositions and methods for treatment of myopia
#1764ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#1765Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
#1766Imaging composition and uses thereof
#1767Pyridine derivatives
#1768Inhibitors of protein kinases
#1769Dantrolene prodrugs and methods of their use
#1770Sulfonyl substituted bicyclic compound which acts as ROR inhibitor
#1771Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
#1772EBNA1 inhibitors and methods using same
#17733-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators
#17743-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
#1775Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders
#1776Biaryloxy derivatives as TTX-S blockers
#1777Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#1778Viral replication inhibitors
#1779Phenyl propionic acid derivatives and uses thereof
#1780Processes for the preparation of Tezacaftor and intermediates thereof
#1781Bisamide sarcomere activating compounds and uses thereof
#1782Bisamide sarcomere activating compounds and uses thereof
#1783Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#1784Method of treating or preventing Ras-mediated diseases
#1785Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#1786Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#1787Prodrugs of urolithins and uses thereof
#17885-hydroxytryptamine receptor 7 activity modulators and their method of use
#1789P2X4 receptor antagonist
#1790Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same
#1791PPAR agonists and methods of use thereof
#1792Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
#1793BENZOFURAN UREAS OR CARBAMATES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY
#1794Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
#17955-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#1796Tripeptide epoxy ketone protease inhibitors
#1797Glutarimides for medical treatment
#1798DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE
#1799Dihydrobenzimidazolones for medical treatment
#1800Compounds for use as therapeutically active substances in the treatment of retinal diseases